{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"22"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"42"}],"units":"Participants"}],"description":"In complete remission, all signs and symptoms of cancer that can be detected with modern technology have disappeared, although cancer still may be in the body.","groups":[{"description":"Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 IV over 30 minutes DLI Cell Dose 1.0 x 10\\^8 CD3+ T-cells/kg","id":"OG000","title":"DLI Cell Dose of 1.0 x 10^8 CD3+ T-cells/kg"},{"description":"Cyclophosphamide 60mg/kg IV over 2 hours Fludarabine 25 mg/m2 DLI Cell Dose 0.5 x 10\\^8 CD3+ T-cells/kg","id":"OG001","title":"DLI Cell Dose of 0.5 x 10^8 CD3+ T-cells/kg"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"one year","title":"Number of Participants With Complete Remission","type":"SECONDARY","unitOfMeasure":"Participants"}